Cellular origin of platelet-derived microparticles in vivo

Andreas Rank1, Rienk Nieuwland, Ruth Delker

  • 1Medizinische Klinik III-Großhadern, Klinikum der Ludwig Maximilians-Universität München, Marchioninistraße 15, 81377 München, Germany. andreas.rank@med.uni-muenchen.de

Thrombosis Research
|August 11, 2010
PubMed
Abstract

Insights

Platelet-derived microparticles (PMP) expressing CD61 decline faster than platelets after irradiation, suggesting megakaryocyte origin. Other PMP markers indicate platelet origin.

Area of Science:

  • Hematology
  • Cell Biology
  • Biomedical Science

Background:

  • Microparticles (MP) are abundant in blood, primarily assumed to be platelet-derived.
  • The origin of MP from megakaryocytes remains unclear.
  • Hematopoietic stem cell transplantation involves total body irradiation, causing hematopoiesis destruction.

Purpose of the Study:

  • To investigate the origin of "platelet-derived" microparticles (PMP).
  • To differentiate between platelet and megakaryocyte origins of PMP.
  • To analyze PMP kinetics following total body irradiation.

Main Methods:

  • Studied 13 patients undergoing total body irradiation (12 Gy).
  • Isolated and double-stained PMP with annexin V and anti-CD61.
  • Analyzed PMP expressing P-selectin or CD63 in 6 patients.

Main Results:

  • PMP levels declined 2.4-fold faster than platelet disappearance post-irradiation.
  • Kinetics of PMP exposing P-selectin or CD63 mirrored platelet disappearance.
  • CD61-positive MP showed a distinct, faster decline compared to other PMP markers.

Conclusions:

  • MP exposing P-selectin or CD63 likely originate from platelets.
  • A significant fraction of CD61-exposing MP appears to originate from megakaryocytes in vivo.
  • Irradiation provides a model to distinguish PMP origins based on marker expression.